A randomized, double-masked, placebo controlled. parallel group study of the effects of loteprednol etabonate 0.2% ophthalmic suspension (LE) in patients with seasonal allergic conjunctivitis

Investigative Ophthalmology and Visual Science

Volumn 38, Issue 4, 1997, Pages

  Strahlman, E ^a   Howes, J ^a  

^a BAUSCH AND LOMB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 2642590440     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)